A Novel Method For Deriving Intersubject Variability For Baseline Hazard Rates and Relative Risks...
1
CLINICALPHARMACOLOGY & THERAPEUTICS P88 American Society3'br Clinical Pharmacology and ~iherapeutics FEBRUARY2003 PIII-94 A NOVEL METHOD FOR DERIVING INTERSUBJECT VARI- ABILITY FOR BASELINE HAZARD RATES AND RELATIVE RISKS FOR SECONDARY VASCULAR EVENTS. H~ Lee, PhD~ S. Tannenbaum, PhD, C. C. Peck, MD, Center for Drug Development Science, Georgetown University, Washington, DC. The intersubject variability (ISV) for baseline hazard rate (Xo) or for relative risk (rr) of developing a disease for a certain risk factor is an important system parameter in a clinical outcome disease Center
Transcript of A Novel Method For Deriving Intersubject Variability For Baseline Hazard Rates and Relative Risks...
CLINICAL PHARMACOLOGY & THERAPEUTICS P 8 8 American Society3'br Clinical Pharmacology and ~iherapeutics FEBRUARY2003
PIII-94 A NOVEL METHOD FOR DERIVING INTERSUBJECT VARI-
ABILITY FOR BASELINE HAZARD RATES AND RELATIVE RISKS FOR SECONDARY VASCULAR EVENTS. H~ Lee, PhD~ S. Tannenbaum, PhD, C. C. Peck, MD, Center for Drug Development Science, Georgetown University, Washington, DC.
The intersubject variability (ISV) for baseline hazard rate (Xo) or for relative risk (rr) of developing a disease for a certain risk factor is an important system parameter in a clinical outcome disease Center
